Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany;
Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Anticancer Res. 2022 Oct;42(10):4825-4831. doi: 10.21873/anticanres.15987.
BACKGROUND/AIM: The aim of this study was to analyze the predictive and prognostic value of the peritoneal cancer index (PCI) with regard to complete cytoreduction and clinical outcomes in patients with high-grade serous ovarian cancer.
In a cohort comprising 188 patients with high-grade serous ovarian cancer, the PCI was retrospectively assessed. Clinical factors and perioperative complications were analyzed according to different PCI groups. Five-year disease-free survival (DFS) and overall survival (OS) were calculated based on the Kaplan-Meier Log rank analysis. Receiver operating characteristic (ROC) analysis was applied to detect associations of PCI and complete cytoreduction. Multivariate survival analysis was performed by Cox proportional hazards model.
In our study, the PCI was predictive of complete cytoreduction (ROC analysis; AUC 0.8227). In patients with optimal cytoreduction, higher PCI scores were associated with poorer 5-year OS (p<0.001) and 5-year DFS (p<0.001). Complications (G1-G5) were significantly more frequent in patients with PCI scores >9 (p=0.0023). Five-year OS was reduced in patients with severe complications compared to patients with none or mild complications (30.88% versus 51.01%; p=0.001). There were significant OS (p<0.001) and DFS (p<0.001) differences between patients with none or mild versus severe complications following complete cytoreduction within the PCI subgroups (PCI: 9-11, PCI: 12-18, PCI >18).
The PCI score showed high predictability for complete cytoreduction and was associated with clinical outcomes. In presence of severe complications, higher PCI scores were associated with poorer survival. Hence, in patients with high tumor load, the prevention of severe perioperative complications is of utmost importance in all cases where complete cytoreduction is deemed to be feasible.
背景/目的:本研究旨在分析腹膜癌指数(PCI)对于高级别浆液性卵巢癌患者完全肿瘤减灭术和临床结局的预测和预后价值。
在包含 188 例高级别浆液性卵巢癌患者的队列中,回顾性评估了 PCI。根据不同的 PCI 组分析了临床因素和围手术期并发症。基于 Kaplan-Meier Log rank 分析计算了 5 年无病生存率(DFS)和总生存率(OS)。应用受试者工作特征(ROC)分析检测 PCI 和完全肿瘤减灭术之间的相关性。通过 Cox 比例风险模型进行多变量生存分析。
在本研究中,PCI 可预测完全肿瘤减灭术(ROC 分析;AUC 为 0.8227)。在最佳肿瘤减灭术患者中,较高的 PCI 评分与较差的 5 年 OS(p<0.001)和 5 年 DFS(p<0.001)相关。PCI 评分>9 的患者并发症(G1-G5)发生率显著更高(p=0.0023)。与无或轻度并发症患者相比,严重并发症患者的 5 年 OS 降低(30.88%比 51.01%;p=0.001)。在完全肿瘤减灭术后的 PCI 亚组(PCI:9-11、PCI:12-18、PCI>18)中,无或轻度与严重并发症患者之间的 OS(p<0.001)和 DFS(p<0.001)存在显著差异。
PCI 评分对完全肿瘤减灭术具有高度预测性,并与临床结局相关。在存在严重并发症的情况下,较高的 PCI 评分与较差的生存相关。因此,在肿瘤负荷较高的患者中,在所有认为可行完全肿瘤减灭术的情况下,预防严重围手术期并发症至关重要。